156 related articles for article (PubMed ID: 36111932)
1. Circulating miRNA-16 in inflammatory bowel disease and some clinical correlations - a cohort study in Bulgarian patients.
Atanassova A; Georgieva A
Eur Rev Med Pharmacol Sci; 2022 Sep; 26(17):6310-6315. PubMed ID: 36111932
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of serum miR-486 and miR-25 in ulcerative colitis and Crohn's disease: Correlations with disease activity, extent, and location.
Abdelazim SA; Shaker OG; Ali O; El-Tawil M; Senousy MA
Pathol Res Pract; 2023 Dec; 252():154910. PubMed ID: 37939427
[TBL] [Abstract][Full Text] [Related]
3. Tissue and serum miR-149-3p/5p in hospitalized patients with inflammatory bowel disease: Correlation with disease severity and inflammatory markers.
Luo S; Chen XH
Kaohsiung J Med Sci; 2024 Feb; 40(2):131-138. PubMed ID: 37997516
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA signatures differentiate Crohn's disease from ulcerative colitis.
Schaefer JS; Attumi T; Opekun AR; Abraham B; Hou J; Shelby H; Graham DY; Streckfus C; Klein JR
BMC Immunol; 2015 Feb; 16():5. PubMed ID: 25886994
[TBL] [Abstract][Full Text] [Related]
5. Increased circulating circular RNA_103516 is a novel biomarker for inflammatory bowel disease in adult patients.
Ye YL; Yin J; Hu T; Zhang LP; Wu LY; Pang Z
World J Gastroenterol; 2019 Nov; 25(41):6273-6288. PubMed ID: 31749597
[TBL] [Abstract][Full Text] [Related]
6. miR-20b, miR-98, miR-125b-1*, and let-7e* as new potential diagnostic biomarkers in ulcerative colitis.
Coskun M; Bjerrum JT; Seidelin JB; Troelsen JT; Olsen J; Nielsen OH
World J Gastroenterol; 2013 Jul; 19(27):4289-99. PubMed ID: 23885139
[TBL] [Abstract][Full Text] [Related]
7. Oversecretion and Overexpression of Nicotinamide Phosphoribosyltransferase/Pre-B Colony-Enhancing Factor/Visfatin in Inflammatory Bowel Disease Reflects the Disease Activity, Severity of Inflammatory Response and Hypoxia.
Neubauer K; Bednarz-Misa I; Walecka-Zacharska E; Wierzbicki J; Agrawal A; Gamian A; Krzystek-Korpacka M
Int J Mol Sci; 2019 Jan; 20(1):. PubMed ID: 30621173
[TBL] [Abstract][Full Text] [Related]
8. Elevated miRNA Inversely Correlates with
Guz M; Dworzański T; Jeleniewicz W; Cybulski M; Kozicka J; Stepulak A; Celiński K
Biomed Res Int; 2020; 2020():4250329. PubMed ID: 32775420
[TBL] [Abstract][Full Text] [Related]
9. microRNA in inflammatory bowel disease at a glance.
Alamdari-Palangi V; Vahedi F; Shabaninejad Z; Dokeneheifard S; Movehedpour A; Taheri-Anganeh M; Savardashtaki A
Eur J Gastroenterol Hepatol; 2021 Feb; 32(2):140-148. PubMed ID: 32558695
[TBL] [Abstract][Full Text] [Related]
10. Circulating MicroRNA in inflammatory bowel disease.
Paraskevi A; Theodoropoulos G; Papaconstantinou I; Mantzaris G; Nikiteas N; Gazouli M
J Crohns Colitis; 2012 Oct; 6(9):900-4. PubMed ID: 22386737
[TBL] [Abstract][Full Text] [Related]
11. Serum long noncoding RNA H19/micro RNA-675-5p axis as a probable diagnostic biomarker in inflammatory bowel disease.
Shaker OG; Safa A; Khairy A; Abozeid NF
Mol Biol Rep; 2023 Nov; 50(11):9029-9036. PubMed ID: 37716920
[TBL] [Abstract][Full Text] [Related]
12. Tissue and Circulating MicroRNA-31, MicroRNA-200b, and MicroRNA-200c Reflects Disease Activity in Crohn's Disease Patients: Results from the BIOMIR Study.
Tocia C; Dumitru A; Mateescu B; Negreanu L; State M; Cozaru GC; Mitroi AF; Brinzan C; Popescu R; Leopa N; Iordache MM; Manea M; Matei E; Dumitru E; Alexandrescu L
J Gastrointestin Liver Dis; 2023 Mar; 32(1):30-38. PubMed ID: 37004230
[TBL] [Abstract][Full Text] [Related]
13. Expression profile of serum LncRNA THRIL and MiR-125b in inflammatory bowel disease.
Elamir A; Shaker O; Kamal M; Khalefa A; Abdelwahed M; Abd El Reheem F; Ahmed T; Hassan E; Ayoub S
PLoS One; 2022; 17(10):e0275267. PubMed ID: 36206229
[TBL] [Abstract][Full Text] [Related]
14. Circulating and Fecal microRNAs as Biomarkers for Inflammatory Bowel Diseases.
Schönauen K; Le N; von Arnim U; Schulz C; Malfertheiner P; Link A
Inflamm Bowel Dis; 2018 Jun; 24(7):1547-1557. PubMed ID: 29668922
[TBL] [Abstract][Full Text] [Related]
15. LINC00641/miR-378a and Their Cross-Talk with TNF-α/IFN-γ as Potential Biomarkers in Ulcerative Colitis and Crohn's Diseases.
Hameed NAA; Shaker OG; Hasona NA
J Interferon Cytokine Res; 2023 Nov; 43(11):531-537. PubMed ID: 37956249
[TBL] [Abstract][Full Text] [Related]
16. Circulating MicroRNA223 is a New Biomarker for Inflammatory Bowel Disease.
Wang H; Zhang S; Yu Q; Yang G; Guo J; Li M; Zeng Z; He Y; Chen B; Chen M
Medicine (Baltimore); 2016 Feb; 95(5):e2703. PubMed ID: 26844512
[TBL] [Abstract][Full Text] [Related]
17. Faecal Micro-RNAs in Inflammatory Bowel Diseases.
Verdier J; Breunig IR; Ohse MC; Roubrocks S; Kleinfeld S; Roy S; Streetz K; Trautwein C; Roderburg C; Sellge G
J Crohns Colitis; 2020 Jan; 14(1):110-117. PubMed ID: 31209454
[TBL] [Abstract][Full Text] [Related]
18. MicroRNAs in inflammatory bowel disease: What do we know and what can we expect?
de Oliveira ECS; Quaglio AEV; Grillo TG; Di Stasi LC; Sassaki LY
World J Gastroenterol; 2024 Apr; 30(16):2184-2190. PubMed ID: 38690020
[TBL] [Abstract][Full Text] [Related]
19. MicroRNAs as Innovative Biomarkers for Inflammatory Bowel Disease and Prediction of Colorectal Cancer.
Masi L; Capobianco I; Magrì C; Marafini I; Petito V; Scaldaferri F
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887337
[TBL] [Abstract][Full Text] [Related]
20. Expression and Clinical Significance of Elafin in Inflammatory Bowel Disease.
Zhang W; Teng G; Wu T; Tian Y; Wang H
Inflamm Bowel Dis; 2017 Dec; 23(12):2134-2141. PubMed ID: 29084078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
